Figure S1
(A) Schematical representation of domain organization of BET family members including BRD4, BRDT, BRD3 and BRD2. (B) Schematical representation of the exon organization of different BRD4 isoforms (BRD4L and BRD4S). (C) Genotype of progeny from crossing between BRD4 dC/+ and BRD4 dC/+ mice at three weeks old.
Figure S2
(A) Schematical representation of the design of CRISPR/Cas9 mediated deletion of the exons 12 to 17 of BRD4 gene in human cells. The location of genotyping primers BRD4-F and BRD4-R were also indicated. (B) Genotyping of BRD4 exon 12 to 17 deleted cells (SgBRD4-dE12-E17) using BRD4-F and BRD4-R primers. (C) Western blot analysis was performed to examine the expression of BRD4 long isoform and short isoform in sgVec and sgBRD4-dE12-E17 cells. (D) Proliferation curve of sgVec and sgBRD4-dE12-E17 cells. (E) Colony formation of sgVec and sgBRD4-dE12-E17 cells. (F) Immunofluorescence using anti-BRD4 antibodies (ab128874) was performed to determine the distribution of BRD4 in nucleus from sgVec and sgBRD4-dE12-E17 293T cells.
